PRAVASTATIN SODIUM

产品名称：PRAVASTATIN SODIUM
上市时间：04/26/2023
NDA/ANDA/BLA:76341
持证商：APOTEX
NDC:60505-1323-1,70518-1938-0,70518-1938-1,71610-637-30,71610-637-45,51655-708-52,63629-7508-4,50268-665-15,50268-666-15,50268-667-15,51655-976-52,71335-0692-4,60505-0169-9,71335-0692-5,72189-059-90,72189-060-90,72189-061-30,72189-061-90,72189-119-90,71205-149-30,71205-149-60,50090-3853-0,72162-1706-3,72162-1706-9,72162-1707-1,72162-1707-3,72162-1707-6,72162-1707-9,72162-1711-2,72162-1711-3,72162-1711-4,72162-1711-9,72789-143-30,70934-418-30,70934-549-30,71335-1243-1,71335-1243-2,71335-1243-3,50090-2024-0,50090-2024-1,50090-2025-0,50090-2025-1,50090-3853-1,71205-149-90,0904-5891-61,0904-5892-61,0904-5893-61,55154-7275-0,55154-7998-0,60505-0168-9,60505-0169-1,60505-0170-8,60505-0169-2,72789-161-30,60505-1323-5,60505-1323-7,71335-1022-1,71335-1022-2,71335-1022-3,71335-1022-4,71335-1022-5,68788-7009-1,68788-7009-2,68788-7009-3,68788-7009-6,68788-7009-8,68788-7009-9,68788-7584-3,68788-7584-6,68788-7584-9,68788-7660-0,68788-7660-2,68788-7660-3,68788-7660-6,68788-7660-8,68788-7660-9,68788-7779-3,68788-7779-6,68788-7779-9,82009-006-10,71335-0692-2,63629-7508-2,60505-0170-7,63629-7508-5,71335-0692-3,60505-0168-4,60505-1323-8,82009-007-10,82009-007-90,82009-008-05,60505-0168-1,60505-0169-7,60505-0170-1,60505-1323-9,60505-0170-5,60505-0168-5,60505-0168-7,71335-0692-1,35356-921-30,60505-0170-9,70518-0549-0,63629-7508-1,63629-7508-3,50268-668-12,60505-0169-5,63629-8833-1,63629-8835-1,63629-8836-1,71205-516-30,71205-516-60,71205-516-90,35356-125-30,35356-919-30,35356-919-90
说明书：https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=dcf45e4f-b46e-6fbb-b67a-2ff619ab1780&type=pdf
批准信：

填写下方邮箱进行订阅,即可获取详细说明书,另有机会获得全处方辅料含量及部分COA等！